Harvard Bioscience Inc. Announces Q224 Earnings Report Date

August 8, 2024

NASDAQ: HBIO

CAMBRIDGE, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience Inc. (HBIO), a global leader in the development, manufacture, and marketing of innovative life science research tools, today announced that it will release its financial results for the second quarter of 2024 on August 8, 2024.

"We are pleased to announce the date for the release of our Q2 2024 financial results," said Jeffrey Duchemin, President and CEO of Harvard Bioscience. "We believe that our strong performance in the first half of the year has positioned us well for continued growth and profitability in the second half. We look forward to sharing our progress with our shareholders and the broader investment community."

Harvard Bioscience's Q2 2024 earnings presentation will be webcast live at 8:30 AM ET on August 8, 2024. A link to the webcast will be available on the Company's website at www.harvardbioscience.com.

About Harvard Bioscience Inc.

Harvard Bioscience is a global leader in the development, manufacture, and marketing of innovative life science research tools. The Company's products are used by scientists and researchers in academia, biotechnology, and pharmaceutical companies around the world. Harvard Bioscience's mission is to enable discovery, safety, and production of tomorrow's therapeutics.